Clinical Trial

Study Compare Adjuvant Chemotherapy, Chemoradiotherapy and Surgery Alone for pN1-2(pT1b-3N1-2M0) Esophageal Carcinoma

Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated November 12, 2021 (before its estimated July 1, 2022 completion). Its status may not reflect the trial's current state.
Summary
A multi-center prospective randomized controlled study was conducted to compare the effects of adjuvant chemotherapy, chemoradiotherapy and surgery alone for the patients with esophageal cancer.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2019-07-03; most recent amendment 2021-11-10.
Status change: Not Yet Recruiting → Recruiting 2019-09-01
Trial Details
NCT Number NCT04009265
Lead Sponsor Fujian Medical University Union Hospital
Conditions Esophageal Squamous Cell Carcinoma
Enrollment 819 participants
Start Date 2019-08-23
Primary Completion 2022-07-01 (estimated)
Study Completion 2027-07-01 (estimated)
Updated on ClinicalTrials.gov 2021-11-12